ABSTRACT
The physiological functions of PrP(C) remain enigmatic, but the central domain, comprising highly conserved regions of the protein may play an important role. Indeed, a large number of studies indicate that synthetic peptides containing residues 106-126 (CR) located in the central domain (CD, 95-133) of PrP(C) are neurotoxic. The central domain comprises two chemically distinct subdomains, the charge cluster (CC, 95-110) and a hydrophobic region (HR, 112-133). The aim of the present study was to establish the individual cytotoxicity of CC, HR and CD. Our results show that only the CD peptide is neurotoxic. Biochemical, Transmission Electron Microscopy and Atomic Force Microscopy experiments demonstrated that the CD peptide is able to activate caspase-3 and disrupt the cell membrane, leading to cell death.
Subject(s)
Neurons/physiology , Peptide Fragments/physiology , PrPC Proteins/physiology , Amino Acid Sequence , Animals , Apoptosis , Benzothiazoles , Caspase 3/metabolism , Cell Membrane Permeability/drug effects , Cells, Cultured , Dimyristoylphosphatidylcholine/chemistry , Enzyme Activation , Fluorescent Dyes/chemistry , Kinetics , Lipid Bilayers/chemistry , Mice , Mice, 129 Strain , Mice, Inbred C57BL , Mice, Knockout , Molecular Mimicry , Molecular Sequence Data , Neurons/drug effects , Peptide Fragments/chemistry , Peptide Fragments/pharmacology , PrPC Proteins/chemistry , PrPC Proteins/pharmacology , Primary Cell Culture , Protein Multimerization , Protein Structure, Tertiary , Thiazoles/chemistryABSTRACT
The high conformational flexibility of peptoids can generate problems in biomolecular selectivity as a result of undesired off-target interactions. This drawback can be counterbalanced by restricting the original flexibility to a certain extent, thus leading to new peptidomimetics. By starting from the structure of an active peptoid as an apoptosis inhibitor, we designed two families of peptidomimetics that bear either 7-substituted perhydro-1,4-diazepine-2,5-dione 2 or 3-substituted 1,4-piperazine-2,5-dione 3 moieties. We report an efficient, solid-phase-based synthesis for both peptidomimetic families 2 and 3 from a common intermediate. An NMR spectroscopic study of 2a,b and 3a,b showed two species in solution in different solvents that interconvert slowly on the NMR timescale. The cis/trans isomerization around the exocyclic tertiary amide bond is responsible for this conformational behavior. The cis isomers are more favored in nonpolar environments, and this preference is higher for the six-membered-ring derivative 3a,b. We propose that the hydrogen-bonding pattern could play an important role in the cis/trans equilibrium process. These hydrogen bonds were characterized in solution, in the solid state (i.e., by using X-ray studies), and by molecular modeling of simplified systems. A comparative study of a model peptoid 10 containing the isolated tertiary amide bond under study outlined the importance of the heterocyclic moiety for the prevalence of the cis configuration in 2a and 3a. The kinetics of the cis/trans interconversion in 2a, 3a, and 10 was also studied by variable-temperature NMR spectroscopic analysis. The full line-shape analysis of the NMR spectra of 10 revealed negligible entropic contribution to the energetic barrier in this conformational process. A theoretical analysis of 10 supported the results observed by NMR spectroscopic analysis. Overall, these results are relevant for the study of the peptidomimetic/biological-target interactions.
Subject(s)
Peptidomimetics/chemistry , Peptoids/chemistry , Protein Conformation , Amides/chemistry , Crystallography, X-Ray , Drug Design , Hydrogen Bonding , Isomerism , Magnetic Resonance Spectroscopy , Molecular Structure , Peptidomimetics/chemical synthesis , Peptoids/chemical synthesisABSTRACT
BACKGROUND: Several pathways that control cell survival under stress, namely RNF8-dependent DNA damage recognition and repair, PCNA-dependent DNA damage tolerance and activation of NF-kappaB by extrinsic signals, are regulated by the tagging of key proteins with lysine 63-based polyubiquitylated chains, catalyzed by the conserved ubiquitin conjugating heterodimeric enzyme Ubc13-Uev. METHODOLOGY/PRINCIPAL FINDINGS: By applying a selection based on in vivo protein-protein interaction assays of compounds from a combinatorial chemical library followed by virtual screening, we have developed small molecules that efficiently antagonize the Ubc13-Uev1 protein-protein interaction, inhibiting the enzymatic activity of the heterodimer. In mammalian cells, they inhibit lysine 63-type polyubiquitylation of PCNA, inhibit activation of NF-kappaB by TNF-alpha and sensitize tumor cells to chemotherapeutic agents. One of these compounds significantly inhibited invasiveness, clonogenicity and tumor growth of prostate cancer cells. CONCLUSIONS/SIGNIFICANCE: This is the first development of pharmacological inhibitors of non-canonical polyubiquitylation that show that these compounds produce selective biological effects with potential therapeutic applications.
Subject(s)
Proteins/metabolism , Ubiquitination , Animals , Catalysis , HeLa Cells , Humans , Mice , Models, Animal , Models, Molecular , NF-kappa B/metabolism , Protein BindingABSTRACT
We have identified a family of peptoids that inhibits in vitro the activity of the apoptosome, a macromolecular complex that activates mitochondrial-dependent apoptosis pathways. The analysis of peptide-based cell compatible delivery systems of the most active peptoid is presented. The active peptoid was then fused to cell penetrating peptides (CPP) as penetratin (PEN-peptoid) and HIV-1 TAT (TAT-peptoid). PEN-peptoid showed greater cell viability and as a consequence better efficiency as an apoptosis inhibitor than the TAT-peptoid. The intracellular trafficking of both inhibitors was studied by flow cytometry and confocal fluorescence microscopy. Finally, the influence of the cargo (peptoid) molecules on the conformational behavior of the CPP in buffers and in membrane mimetic environments was analyzed using circular dichroism (CD) spectroscopy.
Subject(s)
Apoptosis/drug effects , Apoptotic Protease-Activating Factor 1/antagonists & inhibitors , Mitochondria/metabolism , Peptides/pharmacology , Peptoids/pharmacology , Amino Acid Sequence , Apoptosomes/antagonists & inhibitors , Carrier Proteins/chemistry , Cell Line , Cell Line, Tumor , Cell Survival/drug effects , Cell-Penetrating Peptides , Circular Dichroism , Flow Cytometry , Gene Products, tat/chemistry , Humans , Microscopy, Confocal , Mitochondria/drug effects , Molecular Sequence Data , Molecular Structure , Peptides/chemistry , Peptides/pharmacokinetics , Peptoids/chemistry , Peptoids/pharmacokinetics , Protein ConformationABSTRACT
A synthetic method for the preparation of protein-like globular dendrimers derived from a combination of proline, glycine and imidazolidin ring as branching unit is described. The methodology allows the synthesis of novel peptide dendrimers up to fourth generation. Dendrimers were synthesized by a convergent solid-phase peptide synthesis approach. The conformational properties of branched polyproline peptides and proline dendrimers were studied by CD experiments. CD data suggest conformational plasticity of branched peptides for PPI and PPII, and a stable well-defined secondary structure of proline dendrimers for PPII.
Subject(s)
Proline/chemistry , Proteins/chemistry , Chromatography, High Pressure Liquid , Circular Dichroism , Molecular Structure , Protein Structure, SecondaryABSTRACT
A small library of defined peptide dendrimers based on polyproline sequences was designed to demonstrate the feasibility of generating a new type of polymeric agent for therapeutic use. Structural modifications to dendrimer surfaces further enriched the diversity of the library. Data show that the prolinerich dendrimers can be internalized in human epithelial (HeLa) cells, demonstrating the importance of the dendrimeric motif. The promising results described herein suggest that controlled modification of the dendrimer surface should eventually yield proline dendrimers with therapeutic potential.
Subject(s)
Dendrimers/chemistry , Dendrimers/chemical synthesis , Drug Carriers , Gene Library , Proline/chemistry , Animals , COS Cells , Cattle , Cell Survival/drug effects , Chlorocebus aethiops , Culture Media/chemistry , DNA/genetics , DNA/metabolism , Dendrimers/pharmacokinetics , Dendrimers/pharmacology , Dose-Response Relationship, Drug , Electrophoretic Mobility Shift Assay , Gene Expression , Gene Transfer Techniques , Genetic Vectors , HeLa Cells , Humans , Microscopy, Confocal , Serum Albumin, Bovine/pharmacology , Temperature , beta-Galactosidase/metabolismABSTRACT
Second-generation dendrimers have been prepared on solid phase by successive additions of branched polyproline building blocks starting from two different branching units anchored to the solid support. The preparation of Pro-rich building blocks was carried out by stepwise solid-phase synthesis and their iterative addition was performed by a convergent approach, also using solid-phase synthesis. cis-4-Amino-L-proline and imidazolidine-2-carboxylic acid were used as branching units due to their structural resemblance to proline. The optimized strategy allowed the target compounds to be obtained with high purities without the need for purification steps.
Subject(s)
Peptides/chemical synthesis , Chromatography, High Pressure Liquid , Methods , Molecular Structure , Peptides/chemistryABSTRACT
We present a new family of peptide dendrimers based on polyproline helices and cis-4-amino-L-proline as a branching unit. Dendrimers were synthesized by a convergent solid-phase peptide synthesis approach. The conformational transition between polyproline type I helix and polyproline type II helix was observed by circular dichroism in branched polyproline building blocks with more than 14 proline residues and in the resulting dendrimers. Both linear and dendritic polyprolines were found to be actively internalized by rat kidney cells. Preliminary results show that the antibiotic ciprofloxacin form complexes with branched polyproline chains in 99.5% propanol.
